Translation Work 1
The evidence has gotten much stronger that a substance known as C-reactive protein may be every bit as important as cholesterol in the diagnosis and treatment of heart disease. Back in 2002, a thought-provoking study found that a blood test for C-reactive protein, called CRP, was actually better than the standard cholesterol test at predicting the risk of a heart attack or a stroke. Now two studies published in The New England Journal of Medicine have shown that drugs that reduce the levels of that protein in patients with severe heart disease can show the progression of atherosclerosis and prevent heart attacks and cardiac-related deaths.
更有力的证据证明一种被称作C反应蛋白的物质在诊断与治疗心脏疾病中有可能与胆固醇一样重要。

早在2002年，人们在一个发人深省的研究中已发现血液C反应蛋白测试，即CRP，比胆固醇水平测试能更好地预测心脏病或中风的风险。

现今，在《新英格兰医学期刊》中刊登的两则研究表明，用以减少患有严重心脏病的病人中的C反应蛋白水平的药物可以显示病者动脉粥样硬化的进展，并且该种药物还可以预防心脏病、降低因患与心脏相关疾病而死亡的风险。